NIOSH Conformity Assessment Letter to Manufacturers, CA 2022-1041-R1 - NIOSH fraud and fraudulent statements policy and new information about using NIOSH marks. This notice and NIOSH CA 2022-1040 supersede NIOSH CA 2022-1041 and NIOSH CA 2021-1032
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

NIOSH Conformity Assessment Letter to Manufacturers, CA 2022-1041-R1 - NIOSH fraud and fraudulent statements policy and new information about using NIOSH marks. This notice and NIOSH CA 2022-1040 supersede NIOSH CA 2022-1041 and NIOSH CA 2021-1032

  • 07/19/2022

Filetype[PDF-243.82 KB]



Details:

  • Description:
    This NIOSH Fraud and Fraudulent Statements Policy was first included in the February 2021 Conformity Assessment Letter to Manufacturers (NIOSH CA 2021-1032). That notice also offered prioritization guidance and is now superseded by this notice – NIOSH CA 2022-1041R1 (fraud and fraudulent statements) – and NIOSH CA 2022-1040 (February 2022 prioritization guidance).
  • Document Type:
  • CIO:
  • Division:
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov